CAS: 1401436-95-0
![1,3,5-Triazin-2-amine, 4-[2-(difluoromethyl)-1H-benzimidazol-1-yl]-N-[1,1-dimethyl-2-[2-(1-methy...](https://static.cymitquimica.com/products/IN/thumb/DA001C2J.jpg)
1,3,5-Triazin-2-amine, 4-[2-(difluoromethyl)-1H-benzimidazol-1-yl]-N-[1,1-dimethyl-2-[2-(1-methyl-4-piperidinyl)phenyl]ethyl]-6-(4-morpholinyl)-
CAS:1401436-95-0
Fórmula:
C31H38F2N8O
Pureza:
98.79%
Forma y color:
Solid
Peso molecular:
576.6832
Ref: IN-DA001C2J
| 1mg | 588,00 € | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 3 de Diciembre de 2024
Ref: 4Z-Z-040002
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
Ref: 4Z-Z-040001
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
Zandelisib
CAS:1401436-95-0
Zandelisib is a cell-permeable peptide ligand that binds to the extracellular domain of human EGFR. …
Fórmula:
C31H38F2N8O
Pureza:
Min. 95%
Peso molecular:
576.7 g/mol
Ref: 3D-BGC43695
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
Zandelisib
CAS:1401436-95-0
Zandelisib is an inhibitor of phosphatidylinositol 3-kinase (PI3K)(p110δ, IC50 of 3.5 nM), and with antineoplastic …
Fórmula:
C31H38F2N8O
Pureza:
99.15%
Forma y color:
Solid
Peso molecular:
576.68
Ref: TM-T13386
| 1mg | 94,00 € | ||
| 5mg | 174,00 € | ||
| 10mg | 290,00 € | ||
| 25mg | 470,00 € | ||
| 50mg | 634,00 € | ||
| 100mg | 872,00 € | ||
| 200mg | 1.171,00 € | ||
| 1mL*10mM (DMSO) | 217,00 € |
Entrega estimada en Estados Unidos, el Martes 4 de Febrero de 2025
